2.5-11 micron spectroscopy and imaging of AGNs: implication for unification schemes
J. Clavel, B. Schulz, B. Altieri, P. Barr, P. Claes, A. Heras, K., Leech, L. Metcalfe, A. Salama

TL;DR
This study uses 2.5-11 micron spectroscopy and imaging to compare Seyfert 1 and Seyfert 2 galaxies, supporting unification models by revealing differences in MIR continuum and PAH features related to viewing angles and obscuration.
Contribution
It provides new MIR spectroscopic evidence for the unification scheme of AGNs, quantifying extinction and spatially constraining the torus and reflecting regions.
Findings
Sf1 have strong power-law MIR continuum and weak PAH emission.
Sf2s show weak continuum but strong PAH features, indicating higher obscuration.
PAH emission is from bulge ISM, unrelated to nuclear activity.
Abstract
We present 2.5-11 micron spectrophotometric & imaging ISO observations of 28 Sf1, 29 Sf2 & 1 normal galaxy. The Sf1 & Sf2 MIR spectra are statistically different: Sf1 have a strong power-law continuum of index -0.84+/-0.24 & weak PAH emission bands. Sf2s have a weak continuum & very strong PAH emission features with EW (equivalent widths) up to 7.2 micron. On the other hand, the Sf1 and Sf2 PAH luminosities do not differ statistically and the 7 micron continuum is ~8 times less luminous in Sf2s than in Sf1s. The PAH emission is unrelated to the nuclear activity & arises in the bulge ISM. PAH EW are thus a sensitive nuclear redenning indicator. These results are consistent with unified schemes & imply that the Sf2 MIR nuclear continuum is, on the average, extinguished by 92+/-37 visual magnitudes whereas it is directly visible in Sf1s. The dispersion in Sf2's PAH EW is consistent with…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCardiac Imaging and Diagnostics
